• / Free eNewsletters & Magazine
  • / My Account
Home>Authors>Damien Conover

Damien Conover

  1. All
  2. Morningstar Articles
  3. Videos
  4. Investing
  5. Research
  1. Johnson & Johnson's Pharma Group Leading the Way

    The firm's consumer and medical-device group are lagging, but strong results from the pharmaceuticals side should drive earnings throughout this year and into 2015, says Morningstar's Damien Conover .

  2. The Sector Is Fairly Valued, but These Stocks Are Not

    A handful of health-care names are selling at premiums now, but buying opportunities are surfacing, as well.

  3. Prescribe to Pharma for Emerging-Markets Growth

    Many developed-country health-care firms have deep roots in emerging markets and can be a good way to gain exposure, says Morningstar's Damien Conover .

  4. Affordable Care Act: Good or Bad Medicine for the Health-Care Sector?

    As the ultimate impact of Obamacare comes into focus, the sector's winners and losers are becoming more apparent.

  5. Is the Affordable Care Act Healing Health Care’s Woes?

    As the ultimate impact of Obamacare comes into focus, the sector’s winners and losers are becoming more apparent.

  6. The Friday Five

    Five stats from the market and the stories behind them. This week: content kings, patent cliffs, and 30,000 head to Omaha.

  7. Scale and Patent Protection Integral Parts of Lilly's Moat

    Dave Ricks, head of Lilly's Bio-Medicines group, discusses the pharma giant's competitive advantages with Morningstar's Damien Conover .

  8. Big Pharma Dividends Alive and Well

    Pharmaceutical firms' lower-than-historical valuations and high-margin, patent-protected products are positive signs for investors seeking more yield.

  9. Pharma Looking Defensive Again

    Pharmaceutical firms have adapted to their patent cliffs better than investors expected, and solid pricing power and improving pipelines are allowing them to push through macro headwinds.

  10. Health Care’s Outlook Clarifies

    Obamacare will benefit some sectors more than others, but poor economy and pricing pressures are the biggest challenges most health-care firms must face.

Upcoming Events

©2014 Morningstar Advisor. All right reserved.